Literature DB >> 11269224

The hyper-IgE syndrome.

R H Buckley1.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11269224     DOI: 10.1385/CRIAI:20:1:139

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


× No keyword cloud information.
  44 in total

1.  Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E.

Authors:  R E Van Scoy; H R Hill; R E Ritts; P G Quie
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

2.  Recombinant human IL-4 induces IgE and IgG synthesis by normal and atopic donor mononuclear cells. Similar dose response, time course, requirement for T cells, and effect of pokeweed mitogen.

Authors:  J L Claassen; A D Levine; R H Buckley
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

3.  Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections.

Authors:  H R Hill; P G Quie
Journal:  Lancet       Date:  1974-02-09       Impact factor: 79.321

4.  Recurrent severe staphylococcal infections, eczematoid rash, extreme elevations of IgE, eosinophilia, and divergent chemotactic responses in two generations.

Authors:  R Blum; G Geller; L A Fish
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

5.  IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections.

Authors:  M Berger; C H Kirkpatrick; P K Goldsmith; J I Gallin
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

6.  Human IgE synthesis in vitro: a reassessment.

Authors:  H A Sampson; R H Buckley
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

7.  Hyperimmunoglobulinemia E syndrome: association with osteoporosis and recurrent fractures.

Authors:  S G Kirchner; C J Sivit; P F Wright
Journal:  Radiology       Date:  1985-08       Impact factor: 11.105

8.  A hyperimmunoglobulin E syndrome with normal chemotaxis in vitro and defective leukotaxis in vivo.

Authors:  W L Weston; J R Humbert; C S August; J Harnett; M F Mass; P B Dean; I M Hagen
Journal:  J Allergy Clin Immunol       Date:  1977-02       Impact factor: 10.793

9.  Neutrophil and T lymphocyte characteristics of two patients with hyper-IgE syndrome.

Authors:  M Soderberg-Warner; C A Rice-Mendoza; G R Mendoza; E R Stiehm
Journal:  Pediatr Res       Date:  1983-10       Impact factor: 3.756

Review 10.  The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature.

Authors:  H Donabedian; J I Gallin
Journal:  Medicine (Baltimore)       Date:  1983-07       Impact factor: 1.889

View more
  24 in total

Review 1.  Hyper-IgE syndrome update.

Authors:  Kathryn J Sowerwine; Steven M Holland; Alexandra F Freeman
Journal:  Ann N Y Acad Sci       Date:  2012-01-23       Impact factor: 5.691

2.  Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES).

Authors:  Jennifer Heimall; Joie Davis; Pamela A Shaw; Amy P Hsu; Wenjuan Gu; Pam Welch; Steven M Holland; Alexandra F Freeman
Journal:  Clin Immunol       Date:  2011-01-14       Impact factor: 3.969

Review 3.  Differentiation of effector CD4 T cell populations (*).

Authors:  Jinfang Zhu; Hidehiro Yamane; William E Paul
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 4.  Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?

Authors:  Anne Puel; Capucine Picard; Sophie Cypowyj; Desa Lilic; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2010-07-30       Impact factor: 7.486

5.  Acupuncture for symptom management in patients with hyper-IgE (Job's) syndrome.

Authors:  Adeline X Y Ge; Mary E Ryan; Steven M Holland; Alexandra F Freeman; Victoria L Anderson; Fei Wang; Jim W Fleshman
Journal:  J Altern Complement Med       Date:  2011-01-05       Impact factor: 2.579

6.  No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome.

Authors:  E D Renner; I Pawlita; F Hoffmann; V Hornung; D Hartl; M Albert; A Jansson; S Endres; G Hartmann; B H Belohradsky; S Rothenfusser
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

7.  Recurrent hemoptysis with Penicillium marneffei and Stenotrophomonas maltophilia in Job's syndrome.

Authors:  Bosco H M Ma; Calvin S H Ng; Rebecca K Y Lam; Song Wan; Innes Y P Wan; Tak Wai Lee; Anthony P C Yim
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

Review 8.  The hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

Review 9.  [Classification and diagnosis of immunodeficiency syndromes].

Authors:  K Warnatz; H-H Peter
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

10.  Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Authors:  Joshua D Milner; Jason M Brenchley; Arian Laurence; Alexandra F Freeman; Brenna J Hill; Kevin M Elias; Yuka Kanno; Christine Spalding; Houda Z Elloumi; Michelle L Paulson; Joie Davis; Amy Hsu; Ava I Asher; John O'Shea; Steven M Holland; William E Paul; Daniel C Douek
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.